← Browse by Condition
Medical Condition

schizoaffective disorder

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 4, Phase 2

ClinicalMetric tracks all active clinical trials for schizoaffective disorder sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — schizoaffective disorder Clinical Trials

How many clinical trials are currently recruiting for schizoaffective disorder?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for schizoaffective disorder, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for schizoaffective disorder?
schizoaffective disorder research spans Phase 2 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a schizoaffective disorder clinical trial?
Eligibility criteria for schizoaffective disorder trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Phase 4
1
Top Sponsors
VA Office of Research and Development 1 trial
New York State Psychiatric Institute 1 trial
BC Mental Health and Addictions Research Institute 1 trial
Rutgers, The State University of New Jersey 1 trial
Sheppard Pratt Health System 1 trial

Recruiting Clinical Trials

NCT06586164
Recruiting

Enhancing Rehabilitation for Veterans With Serious Mental Illness

Enrollment
80 pts
Location
United States
Sponsor
VA Office of Research and Deve...
View Trial →
NCT06740890 Phase 4
Recruiting

Exercise and Olanzapine-samidorphan

Enrollment
30 pts
Location
United States
Sponsor
New York State Psychiatric Ins...
View Trial →
NCT01392885
Recruiting

Brain Health and Exercise in Schizophrenia

Enrollment
60 pts
Location
Canada
Sponsor
BC Mental Health and Addiction...
View Trial →
NCT06745479
Recruiting

Decision-Making in Schizophrenia: A Combined Neuroimaging and Experience Sampling Study

Enrollment
74 pts
Location
United States
Sponsor
Rutgers, The State University ...
View Trial →
NCT04226898 Phase 2
Recruiting

Synbiotic Compound to Reduce Symptoms of Schizophrenia

Enrollment
68 pts
Location
United States
Sponsor
Sheppard Pratt Health System
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology